Key facts
- This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Feb 2022, 15:59.
Christopher B. Ehrlich - 14 Feb 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 14 Feb 2022
- Net transaction value
- +$13,200
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2022, 15:59:33 UTC
- Prior SEC filing
- 10 Feb 2022
- Next SEC filing
- 13 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 22 Feb 2022.
Change
- Previous filing in this sequence was filed on 10 Feb 2022.
- Current net transaction value: +$13,200.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EFTR
transaction
Common Stock
Purchase
- Transaction value
- $8,900
- Shares
- +2,000
- Change %
- +15%
- Price
- $4.45
- Shares after
- 15,000
- Date
- 14 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
EFTR
transaction
Common Stock
Purchase
- Transaction value
- $4,300
- Shares
- +1,000
- Change %
- +6.7%
- Price
- $4.30
- Shares after
- 16,000
- Date
- 18 Feb 2022
- Ownership
- Direct
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,168
- Date
- 14 Feb 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F2
EFTR
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,034
- Date
- 14 Feb 2022
- Ownership
- By Locust Walk Partners LLC
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at prices ranging from $4.40 to $4.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F2
Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
Footnote F3
Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.